Impact of a perioperative protocol for Parkinson's disease patients on use of contraindicated drugs

Introduction During surgical admissions, the use of antidopaminergic drugs is associated with increased morbimortality and hospital stay in patients with Parkinson's disease (PD) and other parkinsonisms. We implemented a protocol to ensure adequate perioperative pharmacological management i...

Descripción completa

Detalles Bibliográficos
Autores: Salgado Cámara, Paula, De la Casa-Fages, Beatriz, Sanchez-Soblechero, Alberto, Mateo Sierra, Olga, Martín Barbero, M Luisa, Grandas Pérez, Francisco Javier
Tipo de recurso: artículo
Fecha de publicación:2025
País:España
Institución:Universidad Complutense de Madrid (UCM)
Repositorio:Docta Complutense
Idioma:inglés
OAI Identifier:oai:docta.ucm.es:20.500.14352/128227
Acceso en línea:https://hdl.handle.net/20.500.14352/128227
Access Level:acceso abierto
Palabra clave:616.858
Parkinson's disease, Surgery, Perioperative protocol, Contraindicated drugs, Safety
Ciencias Biomédicas
32 Ciencias Médicas
Descripción
Sumario:Introduction During surgical admissions, the use of antidopaminergic drugs is associated with increased morbimortality and hospital stay in patients with Parkinson&apos;s disease (PD) and other parkinsonisms. We implemented a protocol to ensure adequate perioperative pharmacological management in our center, including educational sessions and complementary tools, such as an electronic Pharmacological Alert and a Patient Information Sheet. Objective The objective of this study was to analyze the changes in the prescription of contraindicated medications to PD or parkinsonism patients admitted for surgery, in the three years following implementation of the protocol, and to establish the compliance with the protocol among the medical staff involved in their hospital care over the same period. Methods This is an observational, analytical, prospective study with a before–after design. Results Prescription of contraindicated drugs decreased significantly over the study period (from 57.8% to 20.6%; p<0.001). Patients without an activated Pharmacological Alert had a 13.31 times higher risk of being prescribed contraindicated drugs than patients with such an alert (p<0.001). Neurologists and neurosurgeons used the protocol tools more than Emergency Department surgeons. There was very high compliance with the protocol in admissions for deep brain stimulation and related surgeries. Conclusions The protocol reduced the prescription of contraindicated drugs to PD and parkinsonism patients during their surgical admissions in our center. The Pharmacological Alert and Neurology clinics played a crucial role